FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018508294> ?p ?o ?g. }

• W2018508294 endingPage "4072" @default.
• W2018508294 startingPage "4072" @default.
• W2018508294 abstract "To evaluate the diagnostic value of cancer-testis antigen (CTA) mRNA in peripheral blood samples from hepatocellular carcinoma (HCC) patients.Peripheral blood samples were taken from 90 patients with HCC before operation. Expression of melanoma antigen-1 (MAGE-1), synovial sarcoma X breakpoint-1 (SSX-1), and cancer-testis-associated protein of 11 kDa (CTp11) mRNA in peripheral blood mononuclear cells (PBMC) was tested by nested reverse transcripts-polymerase chain reaction (RT-PCR). Serum alpha-fetoprotein (AFP) in these patients was also determined.The positive rate of MAGE-1, SSX-1 and CTp11 transcripts was 37.7%, 34.4%, 31.1% in PBMC samples, and 74.4%, 73.3%, 62.2% in their resected tumor samples, respectively. The positive rate for at least one of the transcripts of three CTA genes was 66.7% in PBMC samples and 91.1% in their resected tumor samples. MAGE-1, SSX-1 and/or CTp11 mRNA were not detected in the PBMC of those patients from whom the resected tumor samples were MAGE-1, SSX-1 and/or CTp11 mRNA negative, nor in the PBMC samples from 20 healthy donors and 10 cirrhotic patients. Among the 90 patients, the serum AFP in 44 patients met the general diagnostic standard (AFP > 400 microg/L) for HCC, and was negative (AFP < or = 20 microg/L) or positive with a low concentration (20 microg/L < AFP < or = 400 microg/L) in the other patients. The positive rate for at least one of the transcripts of three CTA genes in PBMC samples from the AFP negative or positive patients with a low concentration was 69.2% and 45.0%, respectively. Of the 90 patients, 71 (78.9%) were diagnosed as HCC by nested RT-PCR and serum AFP. Although the positive rate for at least one of the transcripts of three CTA genes in PBMC samples from 53 patients at TNM stage III or IV was obviously higher than that in PBMC samples from 37 patients at stage I or II (77.9% vs 51.4%, P = 0.010), the CTA mRNA was detected in 41.7% and 56.0% of PBMC samples from HCC patients at stages I and II, respectively.Detecting MAGE-1, SSX-1 and CTp11 mRNA in PBMC improves the total diagnostic rate of HCC." @default.
• W2018508294 created "2016-06-24" @default.
• W2018508294 creator A5018580304 @default.
• W2018508294 creator A5027336940 @default.
• W2018508294 creator A5040153820 @default.
• W2018508294 creator A5043578707 @default.
• W2018508294 creator A5069662013 @default.
• W2018508294 creator A5070716760 @default.
• W2018508294 date "2010-01-01" @default.
• W2018508294 modified "2023-10-18" @default.
• W2018508294 title "Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients" @default.
• W2018508294 cites W1509163797 @default.
• W2018508294 cites W1606469159 @default.
• W2018508294 cites W170602106 @default.
• W2018508294 cites W1901932799 @default.
• W2018508294 cites W1918093941 @default.
• W2018508294 cites W1926637130 @default.
• W2018508294 cites W1929693340 @default.
• W2018508294 cites W1969913129 @default.
• W2018508294 cites W1971189741 @default.
• W2018508294 cites W1973911910 @default.
• W2018508294 cites W1985621159 @default.
• W2018508294 cites W1988549390 @default.
• W2018508294 cites W1989238195 @default.
• W2018508294 cites W1995000770 @default.
• W2018508294 cites W2002465379 @default.
• W2018508294 cites W2008792816 @default.
• W2018508294 cites W2016787771 @default.
• W2018508294 cites W2019929939 @default.
• W2018508294 cites W2020830322 @default.
• W2018508294 cites W2022421041 @default.
• W2018508294 cites W2028612069 @default.
• W2018508294 cites W2032976303 @default.
• W2018508294 cites W2035962912 @default.
• W2018508294 cites W2045643041 @default.
• W2018508294 cites W2059295995 @default.
• W2018508294 cites W2060893815 @default.
• W2018508294 cites W2064425349 @default.
• W2018508294 cites W2067497387 @default.
• W2018508294 cites W2070778756 @default.
• W2018508294 cites W2071034864 @default.
• W2018508294 cites W2086229599 @default.
• W2018508294 cites W2088685439 @default.
• W2018508294 cites W2099370196 @default.
• W2018508294 cites W2101040530 @default.
• W2018508294 cites W2106787323 @default.
• W2018508294 cites W2114784224 @default.
• W2018508294 cites W2115260367 @default.
• W2018508294 cites W2117823960 @default.
• W2018508294 cites W2131623367 @default.
• W2018508294 cites W2136744524 @default.
• W2018508294 cites W2140527988 @default.
• W2018508294 cites W2163098129 @default.
• W2018508294 cites W2171505677 @default.
• W2018508294 cites W2189347338 @default.
• W2018508294 cites W2333826431 @default.
• W2018508294 cites W2412505628 @default.
• W2018508294 cites W2426227694 @default.
• W2018508294 cites W2477189357 @default.
• W2018508294 cites W2993035257 @default.
• W2018508294 cites W3152402524 @default.
• W2018508294 doi "https://doi.org/10.3748/wjg.v16.i32.4072" @default.
• W2018508294 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2928462" @default.
• W2018508294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20731022" @default.
• W2018508294 hasPublicationYear "2010" @default.
• W2018508294 type Work @default.
• W2018508294 sameAs 2018508294 @default.
• W2018508294 citedByCount "12" @default.
• W2018508294 countsByYear W20185082942012 @default.
• W2018508294 countsByYear W20185082942013 @default.
• W2018508294 countsByYear W20185082942014 @default.
• W2018508294 countsByYear W20185082942015 @default.
• W2018508294 countsByYear W20185082942018 @default.
• W2018508294 countsByYear W20185082942021 @default.
• W2018508294 crossrefType "journal-article" @default.
• W2018508294 hasAuthorship W2018508294A5018580304 @default.
• W2018508294 hasAuthorship W2018508294A5027336940 @default.
• W2018508294 hasAuthorship W2018508294A5040153820 @default.
• W2018508294 hasAuthorship W2018508294A5043578707 @default.
• W2018508294 hasAuthorship W2018508294A5069662013 @default.
• W2018508294 hasAuthorship W2018508294A5070716760 @default.
• W2018508294 hasBestOaLocation W20185082941 @default.
• W2018508294 hasConcept C121608353 @default.
• W2018508294 hasConcept C126322002 @default.
• W2018508294 hasConcept C137061746 @default.
• W2018508294 hasConcept C142724271 @default.
• W2018508294 hasConcept C147483822 @default.
• W2018508294 hasConcept C202751555 @default.
• W2018508294 hasConcept C203014093 @default.
• W2018508294 hasConcept C2777546739 @default.
• W2018508294 hasConcept C2778019345 @default.
• W2018508294 hasConcept C55493867 @default.
• W2018508294 hasConcept C71924100 @default.
• W2018508294 hasConcept C86803240 @default.
• W2018508294 hasConcept C90924648 @default.
• W2018508294 hasConceptScore W2018508294C121608353 @default.
• W2018508294 hasConceptScore W2018508294C126322002 @default.
• W2018508294 hasConceptScore W2018508294C137061746 @default.

• next